Evidence map›Paper›PMID 28528576›Full record

ArticleBioTechniques2017

Using non-thermal irreversible electroporation to create an in vivo niche for exogenous cell engraftment.

Tammy T Chang, Vivian X Zhou, Boris Rubinsky

Abstract read
In one paragraph

Article in BioTechniques, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Application of pulsed electric field technology to skin engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Normal and fibrotic liver parenchyma respond differently to irreversible electroporation.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tammy T ChangDepartment of Surgery, University of California, San Francisco, CA.
Vivian X ZhouDepartment of Surgery, University of California, San Francisco, CA.
Boris RubinskyDepartment of Mechanical Engineering, University of California, Berkeley, CA.

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
Liver Tissue Engineering Through Three-Dimensional Hepatocyte CultureK08DK093708 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHANG, TAMMY T · 2012 to 2016
$760k
NIDDK NIH HHS K08 DK093708NIDDK NIH HHS P30 DK026743
6 · The paper itself

Abstract

The critical shortage of donor organs has spurred investigation of alternative approaches to either generate replacement organs or implant exogenous cells for treatment of end-stage organ failure. Non-thermal irreversible electroporation (NTIRE), which uses brief high electric field pulses to induce irreversible permeabilization of cell membranes, has emerged as a technique for tumor ablation. Here, we introduce a new application for NTIRE that employs in situ cell ablation to create a niche within a solid organ for engraftment of exogenous cells in vivo. We treated the livers of mice with NTIRE and subsequently implanted exogenous congenic hepatocytes within the zone of cell ablation. Donor hepatocytes engrafted and integrated with host liver parenchyma pre-treated with NTIRE. This new approach should have value for studying the effects of a native matrix scaffold on in vivo cell growth and may pioneer a new type of minimally-invasive regenerative surgery.

Indexed as

Ablation TechniquesAnimalsCells, CulturedCell TransplantationElectroporationHepatocytesLiverMiceMice, Inbred C57BLTemperaturedecellularized scaffoldhepatocyte transplantationirreversible electroporationregenerative surgerytissue engineering

Identifiers

PMID28528576
PMCPMC5709033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.